Blog

Novel Immunotherapy Approaches Moving Through RCC Pipeline – OncLive


OncLive

Novel Immunotherapy Approaches Moving Through RCC Pipeline
OncLive
Zibelman: I spoke about novel immunotherapy options for patients with kidney cancer. I reviewed immunotherapy options that are currently out there with the PD-1 pathway blockade. I also discussed the regimens that are coming on the horizon, which are ...

Flattr this!

2017-10-12 NEWS
About Michael Zand